Endometrial cancer: Predictors of peritoneal failure

Gynecologic Oncology

Volumn 89, Issue 2, 2003, Pages 236-242

  Mariani, Andrea ^a   Webb, Maurice J ^a   Keeney, Gary L ^a   Aletti, Giacomo ^b   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Carcinosis; Cervical invasion; Endometrium; Histologic subtype; Lymph node invasion; Neoplasm; Relapse

Indexed keywords

ADNEXA DISEASE; ADULT; AGED; ASCITES FLUID CYTOLOGY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MYOMETRIUM; PELVIS; PERITONEAL DISEASE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STROMA; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0037405542     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00052-0     Document Type: Conference Paper

References (23)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47.
2. Brown M.R., Masiero L., Kohn E.C. Tumor angiogenesis and metastasis. Hoskins W.J., Perez C.A., Young R.C. Principles and practice of gynecologic oncology. 3rd ed:2000;87-101 Lippincott Williams & Wilkins, Philadelphia.
3. Mariani A., Webb M.J., Keeney G.L., Calori G., Podratz K.C. Hematogenous dissemination in corpus cancer. Gynecol Oncol. 80:2001;233-238. (doi:10.1006/gyno.2000.6058).
4. Mariani A., Webb M.J., Keeney G.L., Aletti G., Podratz K.C. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 84:2002;437-442. (doi:10.1006/gyno.2001.6550).
5. Greven K.M., Lanciano R.M., Corn B., Case D., Randall M.E. Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence. Cancer. 71:1993;3697-3702.
6. Definitions of the clinical stages in carcinoma of the vulva. Gynecol Oncol. 35:1989;125-126.
7. Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg S.G., Wilkinson E.J. Histological typing of female genital tract tumours. 2nd ed:1994;13-18 Springer-Verlag, Berlin.
8. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G., Podratz K.C. Low-risk corpus cancer is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 182:2000;1506-1519.
9. Mayr N.A., Wen B.C., Benda J.A., Sorosky J.I., Davis C.S., Fuller R.W., et al. Postoperative radiation therapy in clinical stage I endometrial cancer corpus, cervical, and lower uterine segment involvement - patterns of failure . Radiology. 196:1995;323-328.
10. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer. 6:1996;102-107.
11. Kasamatsu T., Shiromizu K., Takahashi M., Matsumoto K., Shirai T. Analysis of initial failure site and spread pattern in endometrial carcinoma a Japanese experience . Int J Gynecol Cancer. 9:1999;470-476.
12. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium a Gynecologic Oncology Group study . Gynecol Oncol. 40:1991;55-65.
13. Geisler J.P., Geisler H.E., Melton M.E., Wiemann M.C. What staging surgery should be performed on patients with uterine papillary serous carcinoma? Gynecol Oncol. 74:1999;465-467. (doi:10.1006/gyno.1999.5513).
14. Jordan L.B., Abdul-Kader M., Al-Nafussi A. Uterine serous papillary carcinoma histopathologic changes within the female genital tract . Int J Gynecol Cancer. 11:2001;283-289.
15. Lanciano R.M., Curran W.J. Jr, Greven K.M., Fanning J., Stafford P., Randall M.E., et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 39:1990;368-373.
16. Martinez A., Podratz K., Schray M., Malkasian G. Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity. A prospective clinical trial at the Mayo Clinic. Hematol Oncol Clin North Am. 2:1988;431-446.
17. Mariani A., Webb M.J., Keeney G.L., Aletti G., Podratz K.C. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 86:2002;38-44. (doi:10.1006/gyno.2002.6713).
18. Bristow R.E., Asrari F., Trimble E.L., Montz F.J. Extended surgical staging for uterine papillary serous carcinoma survival outcome of locoregional (stage I-III) disease . Gynecol Oncol. 81:2001;279-286. (doi:10.1006/gyno.2001.6159).
19. Mariani A., Webb M.J., Keeney G.L., Calori G., Podratz K.C. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement. Gynecol Oncol. 83:2001;72-80. (doi:10.1006/gyno.2001.6346).
20. Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Aletti G., Podratz K.C. Stage IIIc endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol. 87:2002;112-117. (doi:10.1006/gyno.2002.6789).
21. Soper J.T., Creasman W.T., Clarke-Pearson D.L., Sullivan D.C., Vergadoro F., Johnston W.W. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol. 153:1985;191-196.
22. Pustilnik T., Burke T.W. Adjuvant chemotherapy for high-risk endometrial cancer. Semin Radiat Oncol. 10:2000;23-28.
23. Randall M.E., Spirtos N.M., Dvoretsky P. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III) Gynecologic Oncology Group Study No. 122 . J Natl Cancer Inst Monogr. 19:1995;13-15.